Skip to main content
. 2023 Mar 22;38(8):853–858. doi: 10.1007/s10654-023-00984-8

Table 2.

Incident cancer diagnoses

STEMI patients Rotterdam study
n = 1809 n = 10,052
All incident cancers 115 677
Cancer subtypes
Upper gastrointestinal 10 (8.7) 30 (4.4)
Hepatobiliary and panreatic 2 (1.7) 27 (4.0)
Colorectal 15 (13.0) 118 (17.4)
Breast 7 (6.1) 107 (15.8)
Prostate 18 (15.7) 111 (16.4)
Genital 1 (0.9) 24 (3.5)
Urologic 11 (9.6) 63 (9.3)
Otolaryngol 3 (2.6) 20 (3.0)
Lung 23 (20.0) 81 (12.0)
Melanoma 9 (7.8) 26 (3.8)
Hematologic 10 (8.7) 37 (5.5)
Other/unknown primary origin 6 (5.2) 33 (4.9)
Metastases at cancer diagnosis 21 (18.3) 97 (14.3)
Incident cancers by follow-up time strata
0–3 Months 15 (13.0) 22 (3.2)
3–6 Months 11 (9.6) 32 (4.7)
6–12 Months 16 (13.9) 66 (9.7)
12–24 Months 26 (22.6) 158 (23.3)
24–60 Months 47 (40.9) 399 (58.9)

Values are counts (percentages among total number of cancer cases)